NEW YORK (GenomeWeb News) – Ambry Genetics has been certified to provide Agilent Technologies' SureSelect Target Enrichment System services for next-generation sequencing projects, Agilent said today.

Ambry, which is located in Aliso Viejo, Calif., received the Certified Service Provider status after demonstrating proficiency using the system with the Illumina Genome Analyzer, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.